My guess - for COVID continue until Phase III interim data available (mid-October). Uplisting commensurate with those results (in our best interest, imo), and no OWS due government pricing and stockpile control after negotiations. HIV BLA update will be key - any BS and we will confirm beyond any reasonable doubt that the FDA has no intention of approving us for anything. UK looks like they are ready to pull the trigger, but will also wait for Phase III interim results. Possible surprise in the CC, but unlikely. Stay Strong / Stay Long!